A genome-wide association study identifies new loci for ACE activity: potential implications for response to ACE inhibitor

[1]  Ricardo J Komotar,et al.  Genomewide Association Studies of Stroke. , 2009, Neurosurgery.

[2]  Tzu-Hao Wang,et al.  A genome-wide association study primer for clinicians. , 2009, Taiwanese journal of obstetrics & gynecology.

[3]  M. Rudnicki,et al.  Significance of genetic polymorphisms of the renin-angiotensin-aldosterone system in cardiovascular and renal disease. , 2009, Pharmacogenomics.

[4]  Eric Boerwinkle,et al.  Replication of the Wellcome Trust genome-wide association study of essential hypertension: the Family Blood Pressure Program , 2008, European Journal of Human Genetics.

[5]  Wen-Harn Pan,et al.  Genome-Wide Scan for Quantitative ACE Activity in Taiwan Young-Onset Hypertension Study , 2007, Human Heredity.

[6]  C. Gieger,et al.  Genomewide association analysis of coronary artery disease. , 2007, The New England journal of medicine.

[7]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[8]  F. Rosendaal,et al.  Predictive genetic variants for venous thrombosis: what's new? , 2007, Seminars in hematology.

[9]  R. Castellon,et al.  Demystifying the ACE polymorphism: from genetics to biology. , 2007, Current pharmaceutical design.

[10]  J. O’Donnell,et al.  ABO blood group determines plasma von Willebrand factor levels: a biologic function after all? , 2006, Transfusion.

[11]  Wen-Harn Pan,et al.  Using endophenotypes for pathway clusters to map complex disease genes , 2006, Genetic epidemiology.

[12]  E. Boerwinkle,et al.  Pharmacogenetic Association of the Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism on Blood Pressure and Cardiovascular Risk in Relation to Antihypertensive Treatment: The Genetics of Hypertension-Associated Treatment (GenHAT) Study , 2005, Circulation.

[13]  O. Blumenfeld,et al.  Allelic genes of blood group antigens: A source of human mutations and cSNPs documented in the Blood Group Antigen Gene Mutation Database , 2004, Human mutation.

[14]  I. Gottesman,et al.  The endophenotype concept in psychiatry: etymology and strategic intentions. , 2003, The American journal of psychiatry.

[15]  N. Hooper,et al.  The angiotensin-converting enzyme gene family: genomics and pharmacology. , 2002, Trends in pharmacological sciences.

[16]  R C Elston,et al.  Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. , 2001, American journal of human genetics.

[17]  V. Znojil,et al.  Angiotensin I-converting enzyme (ACE) polymorphism and ABO blood groups as factors codetermining plasma ACE activity. , 1996, Experimental hematology.

[18]  K. Erb,et al.  Review of Studies on the Clinical Pharmacodynamics of Cilazapril , 1994, Journal of cardiovascular pharmacology.

[19]  S. Gottlieb,et al.  First-dose effects of enalapril 2.5 mg and captopril 6.25 mg in patient with heart failure: A double-blind, randomized, multicenter study , 1994 .

[20]  H. Naim,et al.  Human small intestinal angiotensin-converting enzyme: intracellular transport, secretion and glycosylation. , 1993, The Biochemical journal.

[21]  P Corvol,et al.  An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. , 1990, The Journal of clinical investigation.

[22]  J. Riordan,et al.  Angiotensin-converting enzyme: new concepts concerning its biological role. , 1989, Biochemistry.

[23]  K Y Liang,et al.  Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.

[24]  Y Kasahara,et al.  Colorimetry of angiotensin-I converting enzyme activity in serum. , 1981, Clinical chemistry.

[25]  A. Kobata,et al.  The sugar chain structures of ABO blood group active glycoproteins obtained from human erythrocyte membrane. , 1978, The Journal of biological chemistry.

[26]  K. Mossman.  The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[27]  W. O.  ABO ( H ) blood groups and vascular disease : a systematic review and meta-analysis , 2007 .

[28]  Hsing-Yi Chang,et al.  Elderly Nutrition and Health Survey in Taiwan (1999-2000): research design, methodology and content. , 2005, Asia Pacific journal of clinical nutrition.

[29]  S. Gottlieb,et al.  First-dose effects of enalapril 2.5 mg and captopril 6.25 mg in patients with heart failure: a double-blind, randomized, multicenter study. The Enalapril-Captopril Investigators. , 1994, American heart journal.

[30]  P. Corvol,et al.  Distribution of plasma angiotensin I-converting enzyme levels in healthy men: relationship to environmental and hormonal parameters. , 1991, The Journal of laboratory and clinical medicine.

[31]  R. Elston,et al.  ABO associations with blood pressure, serum lipids and lipoproteins, and anthropometric measures. , 1985, Human heredity.

[32]  Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. II. Results of long-term therapy. Veterans Administration Cooperative Study Group on Antihypertensive Agents. , 1982, JAMA.